Compliance under 57(5) as on 30th September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek has informed the BSE that SEBI's Regulation 57(5) does not apply to the company for the quarter ended 30th September 2025. The regulation requires listed entities to certify payment of interest, dividend, or principal on non-convertible securities and disclose any unpaid obligations. Since the company has not issued any non-convertible securities, both the certificate of payment and the details of unpaid obligations are marked as 'Not Applicable.' The letter is signed by Dr. K. Koteswara Rao, Chairman & Managing Director.
This is a routine compliance filing with no material impact on shareholders or the stock. It simply confirms that the company does not have any non-convertible debt instruments outstanding, so no new information about debt servicing or defaults is being disclosed.